UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients

Alimentary pharmacology & therapeutics, 2012-03, Vol.35 (6), p.647-662

2012

Volltextzugriff (PDF)

Despite poor interferon response in advanced hepatitis C virus infection, models of protease inhibitor treatment predict maximum treatment benefit

Alimentary pharmacology & therapeutics, 2012-10, Vol.36 (7), p.670-679

2012

Volltextzugriff (PDF)

Central venous cannulation in patients with liver disease and coagulopathy : a prospective audit

Intensive care medicine, 1999-05, Vol.25 (5), p.481-485

1999

Volltextzugriff (PDF)

Carbamazepine‐induced acute liver failure as part of the DRESS syndrome

International journal of clinical practice (Esher), 2005-08, Vol.59 (8), p.988-991

2005

Volltextzugriff (PDF)

Weight loss during pegylated interferon and ribavirin treatment of chronic hepatitis C

Journal of viral hepatitis, 2005-09, Vol.12 (5), p.531-535

2005

Volltextzugriff (PDF)

Editorial: the association of hepatitis C virus infection and post‐liver transplant diabetes

Alimentary pharmacology & therapeutics, 2015-03, Vol.41 (5), p.488-488

2015

Volltextzugriff (PDF)

Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus

Transplantation, 2006-01, Vol.81 (1), p.7-14

2006

Volltextzugriff (PDF)

Evolution and emergence of a new era of antiviral treatment for chronic hepatitis C infection

International journal of antimicrobial agents, 2014-01, Vol.43 (1), p.17-25

2014

Volltextzugriff (PDF)

Commentary: SOFA scores and staggered paracetamol overdose prognostication

Alimentary pharmacology & therapeutics, 2012-07, Vol.36 (2), p.200-201

2012

Volltextzugriff (PDF)

P65 Oral anti-viral therapy shaping the indications for hepatitis B liver transplantation over 2 decades

Gut, 2011-09, Vol.60 (Suppl 2), p.A30-A30

2011

Volltextzugriff (PDF)

Selection of hepatitis B surface “escape” mutants during passive immune prophylaxis following liver transplantation: potential impact of genetic changes on polymerase protein function

Gut, 1999-08, Vol.45 (2), p.306-309

1999

Volltextzugriff (PDF)

Serious paracetamol poisoning and the results of liver transplantation

Gut, 1994-06, Vol.35 (6), p.809-814

1994

Volltextzugriff (PDF)

Combined alpha interferon and ribavirin for the treatment of hepatitis C in patients with hereditary bleeding disorders

British journal of haematology, 2000-02, Vol.108 (2), p.254-258

2000

Volltextzugriff (PDF)

Direct visualization and quantitation of cytomegalovirus-specific CD8+ cytotoxic T-lymphocytes in liver transplant patients

Transplantation, 2000-06, Vol.69 (11), p.2251

2000

Volltextzugriff (PDF)

Cytomegalovirus disease following liver transplantation: an analysis of prophylaxis strategies

The Journal of infection, 2003-08, Vol.47 (2), p.104-109

2003

Volltextzugriff (PDF)

Inferior response of Asian vs non-Asian hepatitis C genotype 3 infection to combination antiviral therapy

Journal of viral hepatitis, 2008-02, Vol.15 (2), p.115-119

2008

Volltextzugriff (PDF)

Fungal infection and liposomal amphotericin B (AmBisome) therapy in liver transplantation : a 2 year review

Journal of antimicrobial chemotherapy, 1999-04, Vol.43 (4), p.597-600

1999

Volltextzugriff (PDF)

PRIMARY BILIARY CIRRHOSIS: IDENTIFICATION OF TWO MAJOR M2 MITOCHONDRIAL AUTOANTIGENS

The Lancet (British edition), 1988-05, Vol.331 (8594), p.1067-1070

1988

Volltextzugriff (PDF)

Liver transplantation for fulminant hepatic failure: importance of renal failure

Transplant international, 1997-01, Vol.10 (1), p.55-60

1997

Volltextzugriff (PDF)

Antigenic characterisation of pre- and post-liver transplant hepatitis B surface antigen sequences from patients treated with hepatitis B immune globulin

Journal of hepatology, 1999-08, Vol.31 (2), p.195-201

1999

Volltextzugriff (PDF)

De novo hepatitis B infection acquired during liver transplantation

QJM : An International Journal of Medicine, 2001-05, Vol.94 (5), p.271-275

2001

Volltextzugriff (PDF)

Viral hepatitis in Nigeria—sickle-cell disease and commercial blood donors

QJM : An International Journal of Medicine, 1994-07, Vol.87 (7), p.407-411

1994

Volltextzugriff (PDF)

Respiratory viruses in adult liver transplant recipients

Transplantation, 1999-10, Vol.68 (7), p.981-984

1999

Volltextzugriff (PDF)

Epstein‐Barr virus infection and malignant lymphomas in liver transplant recipients

International journal of cancer, 1997-11, Vol.73 (4), p.514-520

1997

Volltextzugriff (PDF)

Posttransplantation chronic hepatitis in fulminant hepatic failure

Hepatology (Baltimore, Md.), 1997-04, Vol.25 (4), p.1003-1007

1997

Volltextzugriff (PDF)

1 – 25 von 219

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(204)
Mit Volltextzugriff
(165)

Publikationsform

Sprache

Englisch
(217)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients

Despite poor interferon response in advanced hepatitis C virus infection, models of protease inhibitor treatment predict maximum treatment benefit

Central venous cannulation in patients with liver disease and coagulopathy : a prospective audit

Carbamazepine‐induced acute liver failure as part of the DRESS syndrome

Weight loss during pegylated interferon and ribavirin treatment of chronic hepatitis C

Editorial: the association of hepatitis C virus infection and post‐liver transplant diabetes

Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus

Evolution and emergence of a new era of antiviral treatment for chronic hepatitis C infection

Commentary: SOFA scores and staggered paracetamol overdose prognostication

P65 Oral anti-viral therapy shaping the indications for hepatitis B liver transplantation over 2 decades

Selection of hepatitis B surface “escape” mutants during passive immune prophylaxis following liver transplantation: potential impact of genetic changes on polymerase protein function

Serious paracetamol poisoning and the results of liver transplantation

Combined alpha interferon and ribavirin for the treatment of hepatitis C in patients with hereditary bleeding disorders

Direct visualization and quantitation of cytomegalovirus-specific CD8+ cytotoxic T-lymphocytes in liver transplant patients

Cytomegalovirus disease following liver transplantation: an analysis of prophylaxis strategies

Inferior response of Asian vs non-Asian hepatitis C genotype 3 infection to combination antiviral therapy

Fungal infection and liposomal amphotericin B (AmBisome) therapy in liver transplantation : a 2 year review

PRIMARY BILIARY CIRRHOSIS: IDENTIFICATION OF TWO MAJOR M2 MITOCHONDRIAL AUTOANTIGENS

Liver transplantation for fulminant hepatic failure: importance of renal failure

Antigenic characterisation of pre- and post-liver transplant hepatitis B surface antigen sequences from patients treated with hepatitis B immune globulin

De novo hepatitis B infection acquired during liver transplantation

Viral hepatitis in Nigeria—sickle-cell disease and commercial blood donors

Respiratory viruses in adult liver transplant recipients

Epstein‐Barr virus infection and malignant lymphomas in liver transplant recipients

Posttransplantation chronic hepatitis in fulminant hepatic failure

Suchergebnisse filtern